I-Wei Chang1,2, Victor Chia-Hsiang Lin1,3, Chih-Hsin Hung1, Hua-Pin Wang3, Yung-Yao Lin3, Wen-Jeng Wu4,5,6, Chun-Nung Huang4,5,7, Ching-Chia Li4,5,7,8, Wei-Ming Li4,5,7, Jui-Yu Wu9, Chien-Feng Li10,11,12,13. 1. Institute of Biotechnology and Chemical Engineering, I-Shou University, Kaohsiung, Taiwan. 2. Department of Pathology, E-DA Hospital, I-Shou University, Kaohsiung, Taiwan. 3. Department of Urology, E-DA Hospital, I-Shou University, Kaohsiung, Taiwan. 4. Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. 5. Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. 6. Department of Urology, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan. 7. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. 8. Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan. 9. College of Medicine, Taipei Medical University, Taipei, Taiwan. 10. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. angelo.p@yahoo.com.tw. 11. Department of Pathology, Chi Mei Foundation Medical Center, No. 901, Zhonghua Rd., Yongkang Dist., Tainan, 701, Taiwan. angelo.p@yahoo.com.tw. 12. Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. angelo.p@yahoo.com.tw. 13. Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan. angelo.p@yahoo.com.tw.
Abstract
PURPOSE: Oxidative stress is believed to be one of the important etiologies in carcinogenesis that has not been systemically investigated in urothelial carcinoma (UC). Through data mining from a published transcriptomic database of UC of urinary bladders (UBUCs) (GSE31684), glutathione peroxidase 2 (GPX2) was identified as the most significant downregulated gene among those response to oxidative stress (GO:0006979). We therefore analyze GPX2 transcript and protein expressions and its clinicopathological significance. METHODS: Real-time RT-PCR assay was used to detect GPX2 mRNA level in 20 fresh UBUC specimens. Immunohistochemistry was used to determine GPX2 protein expression in 340 urothelial carcinomas of upper tracts (UTUCs) and 295 UBUCs with mean/median follow-up of 44.7/38.9 and 30.8/23.1 months, respectively. Its expression status was further correlated with clinicopathological features and evaluated for its impact on disease-specific survival and metastasis-free survival (MeFS). RESULTS: Decrease in GPX2 transcript level was associated with both higher pT and positive nodal status in 20 UBUCs (all p < 0.05). GPX2 protein underexpression was also significantly associated with advanced pT status, nodal metastasis, high histological grade, vascular invasion, and frequent mitoses in both groups of UCs (all p < 0.05). GPX2 underexpression not only predicted dismal DDS and MeFS at univariate analysis, but also implicated worse DDS (UTUC, p = 0.002; UBUC, p = 0.029) and MeFS (UTUC, p = 0.001; UBUC, p = 0.032) in multivariate analysis. CONCLUSIONS: GPX2 underexpression is associated with advanced tumor status and implicated unfavorable clinical outcome of UCs, suggesting its role in tumor progression and may serve as a theranostic biomarker of UCs.
PURPOSE: Oxidative stress is believed to be one of the important etiologies in carcinogenesis that has not been systemically investigated in urothelial carcinoma (UC). Through data mining from a published transcriptomic database of UC of urinary bladders (UBUCs) (GSE31684), glutathione peroxidase 2 (GPX2) was identified as the most significant downregulated gene among those response to oxidative stress (GO:0006979). We therefore analyze GPX2 transcript and protein expressions and its clinicopathological significance. METHODS: Real-time RT-PCR assay was used to detect GPX2 mRNA level in 20 fresh UBUC specimens. Immunohistochemistry was used to determine GPX2 protein expression in 340 urothelial carcinomas of upper tracts (UTUCs) and 295 UBUCs with mean/median follow-up of 44.7/38.9 and 30.8/23.1 months, respectively. Its expression status was further correlated with clinicopathological features and evaluated for its impact on disease-specific survival and metastasis-free survival (MeFS). RESULTS: Decrease in GPX2 transcript level was associated with both higher pT and positive nodal status in 20 UBUCs (all p < 0.05). GPX2 protein underexpression was also significantly associated with advanced pT status, nodal metastasis, high histological grade, vascular invasion, and frequent mitoses in both groups of UCs (all p < 0.05). GPX2 underexpression not only predicted dismal DDS and MeFS at univariate analysis, but also implicated worse DDS (UTUC, p = 0.002; UBUC, p = 0.029) and MeFS (UTUC, p = 0.001; UBUC, p = 0.032) in multivariate analysis. CONCLUSIONS:GPX2 underexpression is associated with advanced tumor status and implicated unfavorable clinical outcome of UCs, suggesting its role in tumor progression and may serve as a theranostic biomarker of UCs.
Authors: M Woenckhaus; L Klein-Hitpass; U Grepmeier; J Merk; M Pfeifer; Pj Wild; M Bettstetter; P Wuensch; H Blaszyk; A Hartmann; F Hofstaedter; W Dietmaier Journal: J Pathol Date: 2006-10 Impact factor: 7.996
Authors: Antje Banning; Anna Kipp; Stephanie Schmitmeier; Maria Löwinger; Simone Florian; Susanne Krehl; Sophie Thalmann; René Thierbach; Pablo Steinberg; Regina Brigelius-Flohé Journal: Cancer Res Date: 2008-12-01 Impact factor: 12.701
Authors: Oliver Hatem Al-Taie; Nurcan Uceyler; Ursula Eubner; Franz Jakob; Hubert Mörk; Michael Scheurlen; Regina Brigelius-Flohe; Katrin Schöttker; Josef Abel; Andreas Thalheimer; Tiemo Katzenberger; Bertram Illert; Ralf Melcher; Josef Köhrle Journal: Nutr Cancer Date: 2004 Impact factor: 2.900
Authors: Fong-Fong Chu; R Steven Esworthy; Peiguo G Chu; Jeffrey A Longmate; Mark M Huycke; Sharon Wilczynski; James H Doroshow Journal: Cancer Res Date: 2004-02-01 Impact factor: 12.701
Authors: Aurélie Mbeutcha; Morgan Rouprêt; Ashish M Kamat; Pierre I Karakiewicz; Nathan Lawrentschuk; Giacomo Novara; Jay D Raman; Christian Seitz; Evanguelos Xylinas; Shahrokh F Shariat Journal: World J Urol Date: 2016-04-21 Impact factor: 4.226
Authors: Aurélie Mbeutcha; Romain Mathieu; Morgan Rouprêt; Kilian M Gust; Alberto Briganti; Pierre I Karakiewicz; Shahrokh F Shariat Journal: Transl Androl Urol Date: 2016-10